Non-invasive Prenatal Testing Market Trends Report 2025 – For Business Development and Strategy Teams

Global Non-invasive Prenatal Testing Market

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Non-invasive Prenatal Testing Market Growth Performance Trended Historically, And What Lies Ahead?

In recent times, there’s been a substantial expansion in the non-invasive prenatal testing market, which is projected to escalate from a worth of $5.48 billion in 2024 to $6.28 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.7%. Factors such as enhanced precision, diminished risks, an uptick in maternal age, rising awareness, and clinical guidelines have significantly contributed to the growth during the previous period.

What Is the Forecast for the Non-invasive Prenatal Testing Market Size Through 2029?

The market size of non-invasive prenatal testing is predicted to witness a swift expansion in the coming years, reaching a valuation of $10.95 billion in 2029 at a Compound Annual Growth Rate (CAGR) of 14.9%. The development during the forecast period can be credited to broader test options, improved accessibility, an upward trend in maternal age, detection of fetal abnormalities, advancements in telemedicine, and digital health. The forecast period is expected to see trends like broader testing panels, increased uptake of non-invasive prenatal testing, technological innovation, and non-invasive fetal aneuploidy diagnosis (nifad).

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2492&type=smp

What are the Key Market Players in Non-invasive Prenatal Testing Market and How They’re Evolving?

Major companies operating in the non-invasive prenatal testing market include F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc., Quest Diagnostics Inc., Agilent Technologies Inc., BGI Diagnosis Co Ltd., Berry Genomics Co, LifeCodexx AG, Myriad Genetics Inc., NIPD Genetics Co Ltd., Sequenom Inc., Annoroad Gene Technology Co Ltd., Centogene AG, Counsyl Inc., EUROFINS Genoma Group, Eurofins Scientific SE, Next Biosciences, Premaitha Health Plc, Ariosa Diagnostics Inc., Beijing Genomics Institute, Yourgene Health PLC, GE Healthcare Technologies Inc., Koninklijke Philips NV, Thermo Fisher Scientific Inc., Pacific Biosciences of California Inc., QIAGEN NV, MedGenome Labs Ltd., Progenity Inc.

What Are the Primary Growth Drivers in the Non-invasive Prenatal Testing Market?

The high prevalence of Down syndrome is a significant catalyst for the growth of the non-invasive prenatal testing market due to the rise in average maternal age, which has prompted concerns about fetal safety. Down syndrome, a chromosomal disorder that occurs when an extra chromosome 21 is mistakenly produced during cell division, can significantly impact a fetus’s cognitive ability and physical growth. Non-invasive prenatal testing (NIPT) screens pose no harm to either the mother or child, and come with no risk of miscarriage, as they are non-invasive, capable of detecting over 99% of Down syndrome cases. Based on data from both the National Down Syndrome Society and the Centres for Disease Control and Prevention, every 1 in 700 babies born in the USA have Down syndrome, and 80% of them are born to mothers over a certain age. This increased risk faced by older women for having children with Down syndrome is a major contributor to the expansion of the non-invasive prenatal testing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2492&type=smp

What Are the Leading Segments in the Global Non-invasive Prenatal Testing Industry?

The non-invasive prenatal testing market covered in this report is segmented –

1) By Type: Consumables, Instruments

2) By Application: Trisomy, Microdeletion, Genetics, Rh factor

3) By End User: Hospital, Diagnostic Labs

Subsegment:

1) By Consumables: Assay Kits, Reagents, Disposables

2) By Instruments: Next-Generation Sequencers (NGS), Polymerase Chain Reaction (PCR) Systems, Ultrasound Devices, Others (Microarrays And Mass Spectrometers)

What Are the Key Market Trends in the Non-invasive Prenatal Testing Industry?

The implementation of next-generation sequencing has notably enhanced throughput, scalability, and speed, facilitating a broad spectrum of applications and allowing for more detailed examination of biological systems. This platform enables simultaneous sequencing of thousands to millions of DNA molecules. The introduction of this technology by manufacturers aims to decrease time and financial expenditure while augmenting output for genome and DNA testing. Prominent companies such as Illumina, Eurofins, Natera, Roche, and Annoroad have applied this technology to non-invasive prenatal testing. The NGS item NextSeq 550AR, produced by Annoroad, has received product registration approval from CFDA (China Food and Drug Administration) for use as a medical instrument.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

What Is the Regional Outlook for the Non-invasive Prenatal Testing Market?

North America was the largest region in the non-invasive prenatal testing market in 2023. Western Europe was the second largest region in the non-invasive prenatal testing market. The regions covered in the non-invasive prenatal testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2492

This Report Delivers Insight On:

1. How big is the non-invasive prenatal testing market, and how is it changing globally?

2. Who are the major companies in the non-invasive prenatal testing market, and how are they performing?

3. What are the key opportunities and risks in the non-invasive prenatal testing market right now?

4. Which products or customer segments are growing the most in the non-invasive prenatal testing market?

5. What factors are helping or slowing down the growth of the non-invasive prenatal testing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model